Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00901979 · ClinicalTrials.gov registry record · Phase 2
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
A Phase 2 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 693
- Enrollment target
NCT00901979 is a Phase 2 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 693 participants.
The verdict
NCT00901979, a Phase 2 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 693 participants
- Enrollment target
Study Summary
This study will assess the effect of LCQ when added to metformin.
Interventions
- DRUG LCQ908A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 693 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00901979
The ClinicalTrials.gov registry entry for NCT00901979 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 693 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LCQ908A is the first listed.
NCT00901979 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00901979 about?
NCT00901979 is a clinical study titled "A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)". This study will assess the effect of LCQ when added to metformin.
What is the current status of trial NCT00901979?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 693 participants. The study started on 2009-04. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00901979?
The interventions under investigation include: LCQ908A (DRUG).
Who is sponsoring clinical trial NCT00901979?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.